629 related articles for article (PubMed ID: 26691333)
1. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
Sohn IS; Kim CJ; Oh BH; Hong TJ; Park CG; Kim BS; Chung WB;
Am J Cardiovasc Drugs; 2016 Apr; 16(2):129-38. PubMed ID: 26691333
[TBL] [Abstract][Full Text] [Related]
2. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
[TBL] [Abstract][Full Text] [Related]
3. Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.
Chrysant SG; Littlejohn T; Izzo JL; Kereiakes DJ; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
Am J Cardiovasc Drugs; 2012 Aug; 12(4):233-43. PubMed ID: 22799613
[TBL] [Abstract][Full Text] [Related]
4. Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.
Kereiakes DJ; Chrysant SG; Izzo JL; Littlejohn T; Melino M; Lee J; Fernandez V; Heyrman R
Cardiovasc Diabetol; 2012 Oct; 11():134. PubMed ID: 23110471
[TBL] [Abstract][Full Text] [Related]
5. Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study.
Lewin AJ; Kereiakes DJ; Chrysant SG; Izzo JL; Oparil S; Lee J; Fernandez V; Melino M
Ethn Dis; 2014; 24(1):41-7. PubMed ID: 24620447
[TBL] [Abstract][Full Text] [Related]
6. Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.
Lewin AJ; Izzo JL; Melino M; Lee J; Fernandez V; Heyrman R
Drugs Aging; 2013 Jul; 30(7):549-60. PubMed ID: 23549909
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
Volpe M; Christian Rump L; Ammentorp B; Laeis P
Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
Hsueh WA; Shojaee A; Maa JF; Neutel JM
Curr Med Res Opin; 2012 Nov; 28(11):1809-18. PubMed ID: 23072496
[TBL] [Abstract][Full Text] [Related]
9. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
Calhoun DA; Crikelair NA; Yen J; Glazer RD
Adv Ther; 2009 Nov; 26(11):1012-23. PubMed ID: 20024680
[TBL] [Abstract][Full Text] [Related]
10. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
Fogari R; Taddei S; Holm-Bentzen M; Baszak J; Melani L; Schumacher K
Clin Drug Investig; 2010; 30(9):581-97. PubMed ID: 20593911
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
Neutel J; Shojaee A; Maa JF
Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
Punzi HA
Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
[TBL] [Abstract][Full Text] [Related]
15. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension.
Kereiakes DJ; Chrysant SG; Izzo JL; Littlejohn T; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
J Clin Hypertens (Greenwich); 2012 Mar; 14(3):149-57. PubMed ID: 22372774
[TBL] [Abstract][Full Text] [Related]
17. Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.
Calhoun DA; Lacourcière Y; Crikelair N; Jia Y; Glazer RD
Curr Med Res Opin; 2013 Aug; 29(8):901-10. PubMed ID: 23721363
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy.
Punzi H; Shojaee A; Maa JF;
Ther Adv Cardiovasc Dis; 2012 Aug; 6(4):149-61. PubMed ID: 22855062
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
[TBL] [Abstract][Full Text] [Related]
20. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
Chrysant SG; Melino M; Karki S; Lee J; Heyrman R
Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
